Senior insider sale
Chief Development Officer at PTC THERAPEUTICS, INC. — senior position signals high conviction
$1.62M
22.86K shares
What this filing means
KLEIN MATTHEW B. plans to sell 22.86K shares of PTC THERAPEUTICS, INC. valued at approximately $1.62M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/4/2026ACC: 0001959173-26-005607
Officer· Chief Development Officer
Since Apr 2020
22.86K
Shares to sell
$1.62M
Approx. market value
10.29K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
8/3/2026
10.29KTotal acquired10.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/3/2026 | Restricted Stock Vesting Compensation | 10.29K | — |
| Total | 10.29K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
12.57K
Market value
$917.1K
5/14/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.29K
Market value
$705.8K
8/4/2026
Total
Units
22.86K
Value
$1.62M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/14/2026 | 12.57K | $917.1K | — | Completed |
| Planned — Approximate Date | ||||
8/4/2026 | 10.29K | $705.8K | NASDAQ | Planned |
| Total | 22.86K | $1.62M | ||